These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 7808210)

  • 1. Designing a simpler high blood cholesterol case detection strategy: are the advantages of the NCEP protocol worth the complexity?
    Hofer T; Weissfeld J
    Med Decis Making; 1994; 14(4):357-68. PubMed ID: 7808210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A mathematical representation of the expert panel's guidelines for high blood cholesterol case-finding and treatment.
    Weissfeld JL; Weissfeld LA; Holloway JJ; Bernard AM
    Med Decis Making; 1990; 10(2):135-46. PubMed ID: 2190057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relative influence of secondary versus primary prevention using the National Cholesterol Education Program Adult Treatment Panel II guidelines.
    Goldman L; Coxson P; Hunink MG; Goldman PA; Tosteson AN; Mittleman M; Williams L; Weinstein MC
    J Am Coll Cardiol; 1999 Sep; 34(3):768-76. PubMed ID: 10483959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Challenges to implementing the current pediatric cholesterol screening guidelines into practice.
    Dennison BA; Jenkins PL; Pearson TA
    Pediatrics; 1994 Sep; 94(3):296-302. PubMed ID: 8065853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implications of changing national cholesterol education program goals for the treatment and control of hypercholesterolemia.
    Persell SD; Lloyd-Jones DM; Baker DW
    J Gen Intern Med; 2006 Feb; 21(2):171-6. PubMed ID: 16390501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Failure of current guidelines for cholesterol screening in urban African-American adolescents.
    Rifai N; Neufeld E; Ahlstrom P; Rimm E; D'Angelo L; Hicks JM
    Pediatrics; 1996 Sep; 98(3 Pt 1):383-8. PubMed ID: 8784361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of an aggressive (U.S.) and a less aggressive (Canadian) policy for cholesterol screening and treatment.
    Krahn M; Naylor CD; Basinski AS; Detsky AS
    Ann Intern Med; 1991 Aug; 115(4):248-55. PubMed ID: 1854109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time-dependent variability in repeated measurements of cholesterol levels: clinical implications for risk misclassification and intervention monitoring.
    Roeback JR; Cook JR; Guess HA; Heyse JF
    J Clin Epidemiol; 1993 Oct; 46(10):1159-71. PubMed ID: 8410100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of currently recommended pediatric dyslipidemia classifications in predicting dyslipidemia in adulthood: evidence from the Childhood Determinants of Adult Health (CDAH) study, Cardiovascular Risk in Young Finns Study, and Bogalusa Heart Study.
    Magnussen CG; Raitakari OT; Thomson R; Juonala M; Patel DA; Viikari JS; Marniemi J; Srinivasan SR; Berenson GS; Dwyer T; Venn A
    Circulation; 2008 Jan; 117(1):32-42. PubMed ID: 18071074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AMG 145, a monoclonal antibody against PCSK9, facilitates achievement of national cholesterol education program-adult treatment panel III low-density lipoprotein cholesterol goals among high-risk patients: an analysis from the LAPLACE-TIMI 57 trial (LDL-C assessment with PCSK9 monoclonal antibody inhibition combined with statin thErapy-thrombolysis in myocardial infarction 57).
    Desai NR; Giugliano RP; Zhou J; Kohli P; Somaratne R; Hoffman E; Liu T; Scott R; Wasserman SM; Sabatine MS
    J Am Coll Cardiol; 2014 Feb; 63(5):430-3. PubMed ID: 24161333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct measurement of low-density-lipoprotein cholesterol is more effective than total cholesterol for the purpose of lipoprotein screening.
    Okada M; Ishida R
    Prev Med; 2001 Mar; 32(3):224-9. PubMed ID: 11277679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapy modifications and low-density lipoprotein cholesterol goal attainment rates associated with the initiation of generic simvastatin.
    Willey VJ; Bullano MF; Shoetan NN; Gandhi SK
    Curr Med Res Opin; 2010 Jan; 26(1):121-8. PubMed ID: 19916706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparisons of referral criteria for public screening of blood cholesterol levels.
    Wones RG; Kerman KM; Hissa DC; Meloy N; Stein EA
    Public Health Rep; 1989; 104(5):425-32. PubMed ID: 2508171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A population-based treat-to-target pharmacoeconomic analysis of HMG-CoA reductase inhibitors in hypercholesterolemia.
    Hilleman DE; Phillips JO; Mohiuddin SM; Ryschon KL; Pedersen CA
    Clin Ther; 1999 Mar; 21(3):536-62. PubMed ID: 10321422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Particle size of LDL is affected by the National Cholesterol Education Program (NCEP) step II diet in dyslipidaemic adolescents.
    Azadbakht L; Mirmiran P; Hedayati M; Esmaillzadeh A; Shiva N; Azizi F
    Br J Nutr; 2007 Jul; 98(1):134-9. PubMed ID: 17445337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Definition and application of the discretionary screening indicators according to the National Cholesterol Education Program for Children and Adolescents.
    Diller PM; Huster GA; Leach AD; Laskarzewski PM; Sprecher DL
    J Pediatr; 1995 Mar; 126(3):345-52. PubMed ID: 7869190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A community-based, randomized trial of ezetimibe added to statin therapy to attain NCEP ATP III goals for LDL cholesterol in hypercholesterolemic patients: the ezetimibe add-on to statin for effectiveness (EASE) trial.
    Pearson TA; Denke MA; McBride PE; Battisti WP; Brady WE; Palmisano J
    Mayo Clin Proc; 2005 May; 80(5):587-95. PubMed ID: 15887425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accuracy of statin assignment using the 2013 AHA/ACC Cholesterol Guideline versus the 2001 NCEP ATP III guideline: correlation with atherosclerotic plaque imaging.
    Johnson KM; Dowe DA
    J Am Coll Cardiol; 2014 Sep; 64(9):910-9. PubMed ID: 25169177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination drug therapy for hypercholesterolemia. The trade-off between cost and simplicity.
    Heudebert GR; Van Ruiswyk J; Hiatt J; Schectman G
    Arch Intern Med; 1993 Aug; 153(15):1828-37. PubMed ID: 8333817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results of the National Cholesterol Education (NCEP) Program Evaluation ProjecT Utilizing Novel E-Technology (NEPTUNE) II survey and implications for treatment under the recent NCEP Writing Group recommendations.
    Davidson MH; Maki KC; Pearson TA; Pasternak RC; Deedwania PC; McKenney JM; Fonarow GC; Maron DJ; Ansell BJ; Clark LT; Ballantyne CM
    Am J Cardiol; 2005 Aug; 96(4):556-63. PubMed ID: 16098311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.